Test Price
950 AED✅ Home Collection Available
Extractable Nuclear Antigens (ENA) / Anti-Nuclear Antibodies (ANA) Qualitative Profile Test in UAE | 950 AED
Executive Summary & Core Metrics
The ENA/ANA Qualitative Profile is a highly sensitive immunoblot assay that simultaneously detects autoantibodies against extractable nuclear antigens (SS-A/Ro, SS-B/La, Sm, RNP, Scl-70, Jo-1) and anti-nuclear antibodies, essential for diagnosing systemic autoimmune rheumatic diseases. Our UAE-based laboratory delivers same-day reports with 99.9% diagnostic sensitivity, supported by ISO 9001:2015 accreditation and complimentary post-test clinical guidance.
ISO Accredited Processing (Immunoblot)
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain (8 AM – 11 PM)
Free result interpretation by specialist team
📞 Direct Insurance Billing Verification via WhatsApp: +971 54 548 8731
Test Overview & Methodology
The ENA/ANA Qualitative Profile uses immunoblot technology to simultaneously identify multiple autoantibodies in a single assay. This method surpasses traditional ELISA by offering multi-analyte detection with higher specificity for target antigens (SS-A, SS-B, Sm, RNP, Scl-70, Jo-1). The test is performed at DNA Labs UAE under strict ISO 9001:2015 quality standards, ensuring reliable results for rheumatologic evaluation.
| Feature | Our Test (ENA/ANA Qualitative Profile) | Closest Alternative (Standard ELISA) |
|---|---|---|
| Methodology | Immunoblot (multi-analyte, ISO 9001:2015) | Single-plex ELISA |
| Turnaround Time | Same Day (sample by 9 AM) | 2–3 working days |
| Cold-Chain Home Collection | ✔ VIP mobile phlebotomy, refrigerated transport | Not standardized |
| Post-Test Guidance | Telephonic specialist correlation | Limited or none |
| Price | 950 AED (includes home collection) | 800–1,200 AED (lab visit only) |
Physician Insight & Safety Protocols
“As a General Practitioner licensed by the DHA (36234132), I explain that the ENA/ANA profile is a powerful tool when integrated with clinical presentation. Positive results should never prompt self-treatment or medication changes without a thorough medical evaluation. Our lab’s complimentary telephonic guidance offers an essential bridge between lab findings and appropriate clinical action.” — Dr. Ajay Singh, MBBS, DHA Registration ID: 36234132
Pre-Test Advisory
No fasting or special preparation is required for the ENA/ANA profile. However, do not discontinue any prescribed immunosuppressants or corticosteroids without consulting your physician, as this may affect test interpretation. The procedure is a simple blood draw collected via VIP mobile phlebotomy in the comfort of your home across all Emirates.
Safety Exclusion Criteria
- Contraindications: Patients with active acute febrile illness or recent vaccination (within 2 weeks) may have transient autoantibody levels; postpone testing until clinically stable.
- Parental Consent: For minors, this test requires written guardian consent.
- Emergency Red Flags: If you experience chest pain, severe joint swelling, difficulty breathing, or new-onset rash with fever, seek emergency care immediately without waiting for test results.
Patient FAQ & Clinical Guidance
1. What does a positive ENA/ANA profile indicate?
A positive result suggests the presence of autoantibodies associated with systemic autoimmune diseases such as lupus, Sjögren’s syndrome, or scleroderma. However, confirmation requires correlation with clinical symptoms and additional lab tests. Our immunoblot assay specifically identifies target antigens (e.g., SS-A, RNP) to aid in differential diagnosis.
2. Do I need to stop medications before the test?
No, but do not alter any prescribed immunosuppressant or corticosteroid therapy without your doctor’s advice. Routine drug regimens do not interfere with the immunoblot assay, so continue medications as usual unless directed otherwise.
3. How soon will I receive results and get interpretation?
Results are reported the same day if the blood sample is received by 9 AM, Monday through Saturday. A complementary telephonic post-test consultation with our clinical team is provided to explain findings and recommend next steps. Reports are delivered via email or patient portal.
UAE Regulatory & Data Privacy Adherence
Data Protection & Compliance
DNA Labs UAE strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient information is encrypted, access is limited to authorized personnel, and results are shared only with licensed healthcare providers. DHA Facility License No. 1143 ensures regulatory oversight for every test performed at our Dubai Healthcare City facility.
Clinical & Logistical Metadata
| Test Name | Extractable Nuclear Antigens (ENA) / Anti-Nuclear Antibodies (ANA) Qualitative Profile |
| Price (AED) | 950 |
| Turnaround Time | Same Day (sample by 9 AM) |
| Sample Type / Matrix | Peripheral whole blood, serum, or plasma |
| Methodology Used | Immunoblot (multi-analyte) |
| ICD-10-CM Code | R76.8 |
| LOINC Code | 100312-1 |
| DHA Facility License & Laboratory Address | License #1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians